Mealey's (September 2, 2020, 8:47 AM EDT) -- HARTFORD, Conn. — A Connecticut state court judge on Aug. 25 granted summary judgment in a Pradaxa gastrointestinal (GI) bleed death case, finding that the plaintiff's claims that defendant Boehringer Ingelheim Pharmaceuticals Inc. failed to warn about the risk of GI bleeds in patients who had gastroesophageal reflux disease (GERD) are preempted by federal law (Tamra Lea Kearns Estep, et al. v. Boehringer Ingelheim Pharmaceuticals, Inc., et al., NoX03 HHD CV17-6075319S, Conn. Super., Hartford Dist.)....